Radius Health, Inc. (RDUS) Social Stream



Radius Health, Inc. (RDUS): $10.08

-0.02 (-0.20%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

B

Add RDUS to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

F

Ranked

#30 of 170

in industry

RADIUS HEALTH INC (RDUS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering RDUS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 6 $30 $18 $23.142 $10.08 129.58%
2021-12-03 7 $30 $16 $22.125 $10.08 119.49%
2021-12-09 7 $30 $9 $15.875 $10.08 57.49%
2021-12-10 7 $30 $7 $14.5 $10.08 43.85%
2022-02-01 6 $20 $7 $11 $10.08 9.13%
2022-03-14 6 $12 $7 $9.666 $10.08 -4.11%
2022-04-25 6 $13 $7 $9.833 $10.08 -2.45%
2022-05-05 6 $13 $7 $9.666 $10.08 -4.11%
2022-05-11 6 $13 $7 $9.333 $10.08 -7.41%
2022-05-19 6 $14 $7 $9.5 $10.08 -5.75%
2022-05-24 7 $14 $6.25 $9.035 $10.08 -10.37%
2022-06-08 8 $14 $7 $9 $10.08 -10.71%
2022-08-09 6 $10 $8 $9.333 $10.08 -7.41%

The Trend in the Analyst Price Target


RDUS's average price target has moved down $15.24 over the prior 13 months.

Over the past 49 weeks, RDUS's average upside potential has been 47.24%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-28 8 31 15 22.140 13.66 62.08%
2021-09-09 8 31 15 22.140 13.00 70.31%
2022-02-25 6 12 7 9.666 8.26 17.02%
2022-04-25 6 13 7 9.833 7.21 36.38%
2022-06-08 8 14 7 9.000 7.28 23.63%

RDUS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 6 0 0 6

The Trend in the Broker Recommendations


RDUS's average broker recommendation rating improved by 0.5 over the prior 30 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RDUS as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, RADIUS HEALTH INC's average analyst price target is greater than 251.93% of them.
  • RDUS has a greater upside potential (average analyst target price relative to current price) than 551.16% of all US stocks.
  • RADIUS HEALTH INC's variance in analysts' estimates is lower than -1150.81% of stocks in the mid market cap category.
  • RADIUS HEALTH INC's number of analysts covering the stock is greater than 741.58% of stocks in the mid market cap category.

Stocks similar to RADIUS HEALTH INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are RCUS, RCKT, and QURE.

Make investment decisions regarding RDUS using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6989 seconds.